Related Experiment Video
Updated: Jul 5, 2026
14:28
Peptide-based Identification of Functional Motifs and their Binding Partners
Published on: June 30, 2013
Peptides derived from repulsive guidance molecule act as antagonists.
Masayoshi Suda1, Katsuhiko Hata, Aika Sawada
1Department of Neurobiology, Graduate School of Medicine, Chiba University, Japan.
Summary
Researchers identified two repulsive guidance molecule-A (RGMa) derived peptides. These peptides act as RGMa antagonists, inhibiting neurite growth and growth cone collapse, offering potential treatments for central nervous system injuries.
Area of Science:
- Neuroscience
- Molecular Biology
- Developmental Biology
Background:
- Repulsive guidance molecule (RGM) is a membrane-bound protein involved in axon guidance.
- RGM plays roles in embryonic development, including neural tube closure.
- RGM inhibition has shown promise in promoting recovery after spinal cord injury.
Purpose of the Study:
- To identify novel antagonists of RGMa.
- To evaluate the therapeutic potential of RGMa-derived peptides for central nervous system (CNS) injuries.
Main Methods:
- Identification of RGMa-derived peptides.
- In vitro assessment of peptide efficacy in suppressing RGMa-induced neurite growth inhibition and growth cone collapse.
Main Results:
- Two RGMa-derived peptides were identified as functional antagonists.
- These peptides dose-dependently inhibited RGMa's effects on neurite growth and growth cone collapse in vitro.
Conclusions:
- RGMa-derived peptides are effective antagonists of RGMa.
- These peptides represent promising therapeutic agents for treating central nervous system injuries.
Related Concept Videos
01:21Chemotaxis and Direction of Cell Migration
Cells can detect chemical cues in their environment and reorganize the cytoskeleton to migrate toward them or away from them. This directional migration, called chemotaxis, is essential during embryogenesis and development, immune response, tissue repair and regeneration, and reproduction. These chemical cues can either attract or repel the cell's movement. For example, axon development is determined by a combination of chemoattractants and chemorepellents that direct the growing axon towards...
01:28Drug-Receptor Interaction: Antagonist
An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.
Antagonists can be classified as competitive or noncompetitive based on their...
Antagonists can be classified as competitive or noncompetitive based on their...
01:29Cholinergic Antagonists: Chemistry and Structure-Activity Relationship
Cholinergic antagonists bind to cholinergic receptors and limit the effects of acetylcholine and other cholinergic agonists. Based on the specific cholinergic receptor affinity, these antagonists are classified as muscarinic or nicotinic. Anticholinergics interrupt parasympathetic innervations while sympathetic innervations remain uninterrupted. Muscarinic antagonists are also called 'muscarinic antagonists', 'antimuscarinics', or 'parasympatholytics'. Nicotinic antagonists are called...
01:30Combined Effects of Drugs: Antagonism
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
01:17Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action
Nondepolarizing neuromuscular blockers induce paralysis by competitively blocking nicotinic acetylcholine receptors at the muscle end plate. Examples include pancuronium, mivacurium, vecuronium, and rocuronium. These quaternary ammonium derivatives are administered intravenously, are poorly absorbed, and are excreted via the kidneys.
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
01:25Drug-Receptor Interaction: Agonist
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous ligand's action.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous ligand's action.